Open Access. Powered by Scholars. Published by Universities.®

Digital Commons Network™

Open Access. Powered by Scholars. Published by Universities.®

PDF

Selected Works

2009

Amresh Srivastava

Articles 1 - 30 of 33

Full-Text Articles in Entire DC Network

Clinical Interview For Psychiatric Assessment, Amresh Srivastava Oct 2009

Clinical Interview For Psychiatric Assessment, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Early Psychosis: A Novel Gateway For Suicide Prevention, Amresh Srivastava Oct 2009

Early Psychosis: A Novel Gateway For Suicide Prevention, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Family Education For Psychosis, Amresh Srivastava Sep 2009

Family Education For Psychosis, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Cannabis & Psychosis: The Interface Emerging Frontiers For Research, Amresh Shrivastava Sep 2009

Cannabis & Psychosis: The Interface Emerging Frontiers For Research, Amresh Shrivastava

Amresh Srivastava

INTRODUCTION: CANNABIS CONTINUES TO AFFECT MENTAL HEALTH. ITS ABUSE IS ON RISE GLOBALLY. IN CANADA A RISE BY 30% IN LAST TEN YEARS HAS BEEN OBSERVED IN HIGH SCHOOL STUDENTS. INTERRELATIONSHIP OF CANNABIS WITH PSYCHOSIS AND SCHIZOPHRENIA IS A COMPLEX ONE. CANNABIS IS HIGHLY COMORBID WITH PSYCHOSIS, & RELATED TO FUNCTIONAL DISABILITY AND OUTCOME. IT POSES SEVERAL CHALLENGES IN UNDERSTANDING CAUSAL RELATIONSHIP FOR COMORBIDITY, UNDERLYING NEUROCHEMICAL BASIS AND SPECIFICS OF SERVICE DEVELOPMENT. PREVALENCE OF CANNABIS VARIES FROM 20 TO 50% EARLY PSYCHOSIS. OBJECTIVE OF THIS PAPER IS TO REVIEW AVAILABLE LITERATURE TO IDENTIFY CHALLENGES FOR NEWER TARGETS OF RESEARCH AND …

Go to article

Response, Remission & Recovery: Need To Review Outcome Measures For Schizophrenia, Amresh Shrivastava, Nilesh Shah Sep 2009

Response, Remission & Recovery: Need To Review Outcome Measures For Schizophrenia, Amresh Shrivastava, Nilesh Shah

Amresh Srivastava

Schizophrenia is a complex neurobehavioral disorder known to be associated with poor outcome. It causes significant disability in patients and burden of care amongst relatives. Outcome in developing countries has been reported to be far better than western world, which has come into scientific scanner recently. Wide gap exists between expectations of outcome amongst patients, relatives, caregivers and professionals, which is possibly because of limitations in measurements tools. Significant number of patients remain marginalized without improvement in social & occupational functioning preventing their integration into mainstream of society despite 'clinically reported good outcome' and significant advancement in treatments. The contemporary …

Go to article

Should Schizoaffective Disorder Be Dropped From Dsm V, Amresh Srivastava Sep 2009

Should Schizoaffective Disorder Be Dropped From Dsm V, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Should Schizoaffective Disorder Be Dropped From Dsm V, Amresh Srivastava Sep 2009

Should Schizoaffective Disorder Be Dropped From Dsm V, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Treatment Resistant Depression, Amresh Srivastava Aug 2009

Treatment Resistant Depression, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Schizophrenia: General Findings And Current Status, Amresh Srivastava Aug 2009

Schizophrenia: General Findings And Current Status, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Coping With Clinical Challenges Of Risk Assessment: Towards A New Comprehensive Instrument, Amresh Srivastava, Charles Nelson Aug 2009

Coping With Clinical Challenges Of Risk Assessment: Towards A New Comprehensive Instrument, Amresh Srivastava, Charles Nelson

Amresh Srivastava

No abstract provided.

Go to article

Switching And Selecting Atypical Antipsychotic Drugs: Paliperidone, Amresh Srivastava Aug 2009

Switching And Selecting Atypical Antipsychotic Drugs: Paliperidone, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Catatonia Yesterday, Today, Tomorrow, Amresh Srivastava Aug 2009

Catatonia Yesterday, Today, Tomorrow, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Coping With Clinical Challenges Of Risk-Assessment, Amresh Srivastava Aug 2009

Coping With Clinical Challenges Of Risk-Assessment, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Coping With Clinical Challenges Of Risk-Assessment, Amresh Srivastava Aug 2009

Coping With Clinical Challenges Of Risk-Assessment, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Coping With Clinical Challenges Of Risk Assessment: Towards A New Comprehensive Instrument, Amresh Srivastava, Charles Nelson Aug 2009

Coping With Clinical Challenges Of Risk Assessment: Towards A New Comprehensive Instrument, Amresh Srivastava, Charles Nelson

Amresh Srivastava

No abstract provided.

Go to article

Catatonia Yesterday, Today, Tomorrow, Amresh Srivastava Aug 2009

Catatonia Yesterday, Today, Tomorrow, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Schizophrenia: General Findings And Current Status, Amresh Srivastava Aug 2009

Schizophrenia: General Findings And Current Status, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Relapse Prevention In Schizophrenia, Amresh Srivastava Aug 2009

Relapse Prevention In Schizophrenia, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Cognition As An Outcome Measure In Schizophrenia, Amresh Srivastava Jul 2009

Cognition As An Outcome Measure In Schizophrenia, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Mood Symptoms As Comorbidity In Schizophrenia, Amresh Srivastava Jul 2009

Mood Symptoms As Comorbidity In Schizophrenia, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Differential Characteristics Of “Good Outcome Schizophrenia” In A Long-Term Ten Years Study, Mumbai, India, Amresh Srivastava, Meghan Thakar, Nilesh Shah, Larry Stitt Jul 2009

Differential Characteristics Of “Good Outcome Schizophrenia” In A Long-Term Ten Years Study, Mumbai, India, Amresh Srivastava, Meghan Thakar, Nilesh Shah, Larry Stitt

Amresh Srivastava

No abstract provided.

Go to article

Coping Up Challenges Of Risk Assessment: Towards A New Scale: Sis-Map, Amresh Srivastava, Charles Nelson Jul 2009

Coping Up Challenges Of Risk Assessment: Towards A New Scale: Sis-Map, Amresh Srivastava, Charles Nelson

Amresh Srivastava

No abstract provided.

Go to article

Outcome In Schizophrenia: How Good Is "Good Outcome" Schizophrenia In Long-Term In Developing Countries, Amresh Srivastava, Meghan Thakar, Nilesh Shah, Larry Stitt Jul 2009

Outcome In Schizophrenia: How Good Is "Good Outcome" Schizophrenia In Long-Term In Developing Countries, Amresh Srivastava, Meghan Thakar, Nilesh Shah, Larry Stitt

Amresh Srivastava

No abstract provided.

Go to article

Complexity And Limitations Of Stress-Endocrine Research In Mental Health, Amresh Srivastava Jul 2009

Complexity And Limitations Of Stress-Endocrine Research In Mental Health, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 1), Amresh Srivastava Jul 2009

Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 1), Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Atypical Antipsychotics And Cognitive Enhancement In Schizophrenia: The Current Status, Amresh Srivastava Jul 2009

Atypical Antipsychotics And Cognitive Enhancement In Schizophrenia: The Current Status, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Interface Of Cannabis And Early Psychosis--Priorities In Research And Service Development, Amresh Srivastava Jul 2009

Interface Of Cannabis And Early Psychosis--Priorities In Research And Service Development, Amresh Srivastava

Amresh Srivastava

Introduction: cannabis continues to affect mental health. Its abuse is on rise globally. In Canada a rise by 30% in last ten years has been observed in high school students. Interrelationship of cannabis with psychosis and schizophrenia is a complex one. Cannabis is highly comorbid with psychosis, & related to functional disability and outcome. It poses several challenges in understanding causal relationship for comorbidity, underlying neurochemical basis and specifics of service development. Prevalence of Cannabis varies from 20 to 50% early psychosis. Objective of this paper is to review available literature to identify challenges for newer targets of research and …

Go to article

Identifying Schizophrenia: Paradigm Shift ‘The Uhr Research’, Amresh Srivastava Jul 2009

Identifying Schizophrenia: Paradigm Shift ‘The Uhr Research’, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 2), Amresh Srivastava Jul 2009

Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 2), Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Assessment In Crisis, Amresh Srivastava Jul 2009

Assessment In Crisis, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Go to article

Next Last